{
    "Trade/Device Name(s)": [
        "SDI CA480 Clinical Chemistry System",
        "Saturno 300 Clinical Chemistry System"
    ],
    "Submitter Information": "HemoDiagnostica, LLC",
    "510(k) Number": "K061879",
    "Predicate Device Reference 510(k) Number(s)": [
        "K872302",
        "K871028",
        "K880078",
        "K880236"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFR",
        "CDQ",
        "JGS",
        "CEM",
        "CGZ",
        "JJE",
        "CDN"
    ],
    "Summary Letter Date": "November 22, 2006",
    "Summary Letter Received Date": "November 27, 2006",
    "Submission Date": "June 29, 2006",
    "Regulation Number(s)": [
        "21CFR862.2160",
        "21CFR862.1600",
        "21CFR862.1170",
        "21CFR862.1665",
        "21CFR862.1770",
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose",
        "Blood Urea Nitrogen (BUN)",
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SDI CA480 Clinical Chemistry System"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric analyzer",
        "ISE (Ion-Selective Electrode) module"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for SDI CA480 Clinical Chemistry System for quantitative measurement of glucose, BUN, sodium, potassium, and chloride in serum and plasma.",
    "Indications for Use Summary": "Intended for in vitro diagnostic quantitative measurement of glucose, blood urea nitrogen (BUN), sodium, potassium, and chloride in serum for diagnosis and treatment of metabolic and electrolyte disorders.",
    "fda_folder": "Clinical Chemistry"
}